Home News Drug Discovery & Development

Drug Discovery & Development

Decontrolling drug prices: SC refuses to interfere

New Delhi, October 2014 - The Supreme Court on Monday refused to interfere with the Centre's decision to decontrol prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation. "You approach...

Venus Remedies ties up with Israel’s Teva for anti-cancer drug

Chandigarh, August 27, 2014 -  Pharma major Venus Remedies today said it has entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti- cancer drug in the Canadian market. Under this collaboration, Venus Remedies will be initially manufacturing the...

Venus Remedies gets Swiss nod to market oncology drug

Chandigarh, august 21, 2014 - Pharma major Venus Remedies has secured its first marketing authorisation in Switzerland from Swiss drug authority ‘Swissmedic’ for its oncology drug ’Gemcitabine’ The marketing approval for Gemcitabine will help the company further strengthen its oncology...

Glenmark study on novel antibody

MUMBAI, AUGUST 21, 2014: Drugmaker Glenmark Pharmaceuticals is set to initiate studies on its novel drug candidate, GBR 1302, an antibody with dual specificities. Explaining the significance of the discovery, Michael Buschle, Glenmark’s Chief Scientific Officer and President (Biologics) said...

Cipla bets big on cell therapy

Mumbai , March 22,2014 - Stem cells are set to be a major branch of medical treatment, says Cipla Chairman YK Hamied. Regenerative medicine, or cell therapy, is a rapidly emerging area of biomedical research and would be...

AstraZeneca to shut R&D centre in Bangalore

168 research jobs at stake; had during 2012 shed some R&D jobsBangalore January 31, 2014: AstraZeneca, the global pharmaceutical major,  said that it will close its research and development site in Bangalore later this year.  The ‘Avishkar R&D Site’,...

‘New drug for Alzheimer’s, Parkinson’s in the pipeline’

New Delhi December 28, 2013: The Government’s drug price control order may have impacted drug-makers’ profitability, but Chennai-based Arvind Remedies Ltd is unfazed. A new drug to combat Alzheimer’s and Parkinson’s diseases is in the pipeline, says B. Arvind...

Baxter Advances Clinical Practice of Intravenous (IV) Therapy with Launch of Plasma-Lyte A...

  Bangalore, December, 06’2013 - Baxter India Pvt. Ltd. (MD Anish Bafna, www.baxter.in) a subsidiary of global healthcare company, Baxter International Inc. (NYSE:BAX), announced the launch of Plasma-Lyte A (pH 7.4), a physiologically balanced crystalloid solution, having similar electrolyte...

Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for...

Pipeline of Potential Ocular Therapies to Help Millions Worldwide Suffering from Blinding Diseases Mumbai, India, and Germantown, MD, USA, Oct. 26, 2013 – Sun Pharmaceutical Industries Ltd.(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715), an international specialty pharmaceutical...

The Illustrated Guide to Living with Diabetes in India, a Self-management Guide for Diabetics...

Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.